182 related articles for article (PubMed ID: 29084638)
1. Microwave therapy for cutaneous human papilloma virus infection.
Bristow I; Lim WC; Lee A; Holbrook D; Savelyeva N; Thomson P; Webb C; Polak M; Ardern-Jones MR
Eur J Dermatol; 2017 Oct; 27(5):511-518. PubMed ID: 29084638
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell subsets and immunological milieu in inflammatory human papilloma virus-related skin lesions.
Nakayama Y; Asagoe K; Yamauchi A; Yamamoto T; Shirafuji Y; Morizane S; Nakanishi G; Iwatsuki K
J Dermatol Sci; 2011 Sep; 63(3):173-83. PubMed ID: 21715145
[TBL] [Abstract][Full Text] [Related]
3. Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions.
Viac J; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Immunobiology; 1993 Aug; 188(4-5):392-402. PubMed ID: 7503944
[TBL] [Abstract][Full Text] [Related]
4. Review: antibodies to cutaneous human papillomaviruses.
Antonsson A
J Med Virol; 2012 May; 84(5):814-22. PubMed ID: 22431031
[TBL] [Abstract][Full Text] [Related]
5. A placebo controlled observer blind immunocytochemical and histologic study of epithelium adjacent to anogenital warts in patients treated with systemic interferon alpha in combination with cryotherapy or cryotherapy alone.
Handley JM; Maw RD; Horner T; Lawther H; Walsh M; Dinsmore WW
Genitourin Med; 1992 Apr; 68(2):100-5. PubMed ID: 1316307
[TBL] [Abstract][Full Text] [Related]
6. High viral load of human wart-associated papillomaviruses (PV) but not beta-PV in cutaneous warts independent of immunosuppression.
Köhler A; Meyer T; Stockfleth E; Nindl I
Br J Dermatol; 2009 Sep; 161(3):528-35. PubMed ID: 19519829
[TBL] [Abstract][Full Text] [Related]
7. HPV type in plantar warts influences natural course and treatment response: secondary analysis of a randomised controlled trial.
Bruggink SC; Gussekloo J; de Koning MN; Feltkamp MC; Bavinck JN; Quint WG; Assendelft WJ; Eekhof JA
J Clin Virol; 2013 Jul; 57(3):227-32. PubMed ID: 23518443
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous human papillomavirus infection: manifestations and diagnosis.
Tschandl P; Rosendahl C; Kittler H
Curr Probl Dermatol; 2014; 45():92-7. PubMed ID: 24643180
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types.
de Koning MN; ter Schegget J; Eekhof JA; Kamp M; Kleter B; Gussekloo J; Feltkamp MC; Bouwes Bavinck JN; Purdie KJ; Bunker CB; Proby CM; Meys R; Harwood CA; Quint WG
J Clin Microbiol; 2010 May; 48(5):1706-11. PubMed ID: 20237103
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
11. Immunology of HPV infection and HPV-associated tumors.
Majewski S; Jablonska S
Int J Dermatol; 1998 Feb; 37(2):81-95. PubMed ID: 9542660
[No Abstract] [Full Text] [Related]
12. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
13. HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.
Meys R; Purdie KJ; de Koning MN; Quint KD; Little AM; Baker F; Francis N; Asboe D; Hawkins D; Marsh SG; Harwood CA; Gotch FM; Bunker CB
J Infect Dis; 2016 Jun; 213(11):1717-24. PubMed ID: 26908737
[TBL] [Abstract][Full Text] [Related]
14. Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous warts.
Hogendoorn GK; Bruggink SC; de Koning MNC; Eekhof JAH; Hermans KE; Rissmann R; Burggraaf J; Wolterbeek R; Quint KD; Kouwenhoven STP; Bouwes Bavinck JN
Br J Dermatol; 2018 Jan; 178(1):253-260. PubMed ID: 28646591
[TBL] [Abstract][Full Text] [Related]
15. Detection of high-risk human papillomavirus type 16/18 in cutaneous warts in immunocompetent patients, using polymerase chain reaction.
Payal R; Gupta S; Aggarwal R; Handa S; Radotra BD; Arora SK
Dermatol Online J; 2006 Oct; 12(6):1. PubMed ID: 17083881
[TBL] [Abstract][Full Text] [Related]
16. Interplay between human papillomaviruses and dendritic cells.
Offringa R; de Jong A; Toes RE; van der Burg SH; Melief CJ
Curr Top Microbiol Immunol; 2003; 276():215-40. PubMed ID: 12797450
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics.
Bruggink SC; de Koning MN; Gussekloo J; Egberts PF; Ter Schegget J; Feltkamp MC; Bavinck JN; Quint WG; Assendelft WJ; Eekhof JA
J Clin Virol; 2012 Nov; 55(3):250-5. PubMed ID: 22884670
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytoid dendritic cells and type I interferon in the immunological response against warts.
Saadeh D; Kurban M; Abbas O
Clin Exp Dermatol; 2017 Dec; 42(8):857-862. PubMed ID: 28736973
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and vasodilation in skin warts. Association with HPV infection.
Harada K; Lu S; Chisholm DM; Syrjänen S; Schor AM
Anticancer Res; 2000; 20(6B):4519-23. PubMed ID: 11205298
[TBL] [Abstract][Full Text] [Related]
20. Specific immunity to human papilloma virus (HPV) in patients with genital warts.
Viac J; Staquet MJ; Miguet M; Chabanon M; Thivolet J
Br J Vener Dis; 1978 Jun; 54(3):172-5. PubMed ID: 207383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
